Heart rate reduction for 12 months with ivabradine reduces left ventricular mass in cardiac allograft recipients

Transplantation

Volumn 88, Issue 6, 2009, Pages 835-841

  Doesch, Andreas O ^a   Ammon, Kerstin ^a   Konstandin, Mathias ^a   Celik, Sultan ^a   Kristen, Arnt ^a   Frankenstein, Lutz ^a   Buss, Sebastian ^a   Hardt, Stefan ^a   Sack, Falk Udo ^a   Katus, Hugo A ^a   Dengler, Thomas J ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Heart rate; Heart transplantation; Ivabradine; Left ventricular mass.; Sinus tachycardia

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EVEROLIMUS; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IVABRADINE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

ADULT; AGED; ARTICLE; BRADYCARDIA; CARDIAC GRAFT REJECTION; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DIZZINESS; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EXPOSURE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEART DENERVATION; HEART GRAFT; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEART RATE; HOLTER MONITORING; HUMAN; LABORATORY TEST; MALE; NAUSEA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SINUS TACHYCARDIA; SURVIVAL TIME; TREATMENT DURATION; TREATMENT OUTCOME; TREMOR;

ADOLESCENT; ADULT; AGED; BENZAZEPINES; BLOOD PRESSURE; DENERVATION; FEMALE; HEART RATE; HEART TRANSPLANTATION; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; ION CHANNELS; MALE; MIDDLE AGED; ORGAN SIZE; TACHYCARDIA, SINUS; TIME FACTORS; YOUNG ADULT;

EID: 70350557121     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181b4e0f5     Document Type: Article

References (14)

1. Benetos A, Rudnichi A, Thomas F, et al. Influence of heart rate on mortality in a French population: Role of age, gender, and blood pressure. Hypertension 1999; 33: 44.
2. Dyer AR, Persky V, Stamler J, et al. Heart rate as a prognostic factor for coronary heart disease and mortality: Findings in three Chicago epide-miologic studies. Am J Epidemiol 1980; 112: 736.
3. Jouven X, Desnos M, Guerot C, et al. Predicting sudden death in the population: The Paris prospective study I. Circulation 1999; 99: 1978.
4. Kristal-Boneh E, Silber H, Harari G. The association of resting heart rate with cardiovascular, cancer and all-cause mortality. Eight year follow-up of 3527 male Israeli employees (the CORDIS Study). Eur Heart J 2000; 21: 116.
5. Levine HJ. Rest heart rate and life expectancy. J Am Coll Cardiol 1997; 30: 1104.
6. Seccareccia F, Pannozzo F, Dima F, et al. Heart rate as a predictor of mortality: The MATISS project. Am J Public Health 2001; 91: 1258.
7. Doesch AO, CelikS,EhlermannP,et al. Heart rate reduction after heart transplantation with beta-blocker versus the selective If channel antagonist ivabradine. Transplantation 2007; 84: 988.
8. Tardif JC, Ford I, Tendera M, et al. Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina. Eur Heart J 2005; 26: 2529.
9. Zhang R, Haverich A, Struber M, et al. Effectsof ivabradine on allograft function and exercise performance in heart transplant recipients with permanent sinus tachycardia. Clin Res Cardiol 2008; 97: 811.
10. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 1986; 57: 450.
11. Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition 1989; 5: 303.
12. Sahn DJ, DeMaria A,Kisslo J, et al. Recommendations regarding quan-titation in M-mode echocardiography: Results of a survey of echocar-diographic measurements. Circulation 1978; 58: 1072.
13. Bader FM, Hagan ME, Crompton JA, et al. The effect of beta-blocker use on cyclosporine level in cardiac transplant recipients. J Heart Lung Transplant 2005; 24: 2144.
14. Thollon C, Bedut S, Villeneuve N, et al. Use-dependent inhibition of hHCN4 by ivabradine and relationship with reduction in pacemaker activity. Br J Pharmacol 2007; 150: 37.